Expansion aims to continue create programs that address health and education inequities.
With the goal of diversifying clinical trials, break down economic and educational barriers, and create greater trust across research and development, Novartis has announced the inclusion of six new organizations to its Beacon of Hope Initiative. The pharmaceutical corporation selected the new companies in order to provide tools and expertise to enable the Historically Black Medical School Centers of Excellence to accelerate progress on increasing diversity, equity and inclusion in clinical trials, and support new research into healthcare disparities.
According to Novartis, each collaborator comes with a unique skillset. Advarra will support clinical trial-site management, BeeKeeperAI is providing a privacy-preserving collaboration platform that enables protected algorithms to compute on real-world data, and Virb will help with the sourcing and training of clinical trial coordinators and research study staff. In addition, pharmaceutical companies Amgen and Alnylam are joining the initiative to run clinical trials through the Centers of Excellence. Alnylam plans on using the initiative to train under-represented students for careers in drug development.
Lastly, the Global Black Economic Forum (GBEF) is joining the Beacon of Hope in order to share its mission to empower the next generation of diverse leaders in STEM while working to address economic disparities. GBEF plans on offering career training and leadership development programs to students enrolled in Novartis and Thurgood Marshall College Fund (TMCF) scholarship and mentorship program.
“Our relentless commitment to the success of Beacon of Hope led us to undertake a comprehensive assessment of where we have made important progress, and where we still have gaps to fulfilling the mission of the program,” said Linda Armstrong, US Novartis Foundation President, head of Novartis US corporate responsibility. “We actively sought out collaborations with organizations that both possess the expertise necessary to bridge these gaps – particularly on the technology front – and that share our unwavering mission to tackle the fundamental factors that contribute to health and education disparities.”
Reference: Novartis strengthens commitment to Beacon of Hope initiative, engages new collaborators to support clinical trial diversity, break down economic and education barriers. July 11, 2023
Source link
#Novartis #Reveals #Collaborators #Beacon #Hope #Initiative
